US 12122837
Oncostatin M receptor antigen binding proteins
granted A61KA61K39/395A61P
Quick answer
US patent 12122837 (Oncostatin M receptor antigen binding proteins) held by Kiniksa Pharmaceuticals, GmbH expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kiniksa Pharmaceuticals, GmbH
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K39/395, A61P, A61P1/16, A61P1/18